206 related articles for article (PubMed ID: 32764138)
1. Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes.
Gupta N; Wang X; Wen X; Moran P; Paluch M; Hass PE; Heidersbach A; Haley B; Kirchhofer D; Brezski RJ; Peterson AS; Scales SJ
J Am Soc Nephrol; 2020 Sep; 31(9):2065-2082. PubMed ID: 32764138
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes.
Scales SJ; Gupta N; De Mazière AM; Posthuma G; Chiu CP; Pierce AA; Hötzel K; Tao J; Foreman O; Koukos G; Oltrabella F; Klumperman J; Lin W; Peterson AS
J Am Soc Nephrol; 2020 Sep; 31(9):2044-2064. PubMed ID: 32764142
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes.
Vandorpe DH; Heneghan JF; Waitzman JS; McCarthy GM; Blasio A; Magraner JM; Donovan OG; Schaller LB; Shah SS; Subramanian B; Riella CV; Friedman DJ; Pollak MR; Alper SL
Pflugers Arch; 2023 Mar; 475(3):323-341. PubMed ID: 36449077
[TBL] [Abstract][Full Text] [Related]
4. Coiled-coil binding of the leucine zipper domains of APOL1 is necessary for the open cation channel conformation.
Schaub C; Lee P; Racho-Jansen A; Giovinazzo J; Terra N; Raper J; Thomson R
J Biol Chem; 2021 Sep; 297(3):101009. PubMed ID: 34331942
[TBL] [Abstract][Full Text] [Related]
5. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
6. Distinct APOL1 functions in trypanosomes and kidney podocytes.
Pays E
Trends Parasitol; 2022 Feb; 38(2):104-108. PubMed ID: 34887168
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1.
Sharma AK; Friedman DJ; Pollak MR; Alper SL
FEBS J; 2016 May; 283(10):1846-62. PubMed ID: 26945671
[TBL] [Abstract][Full Text] [Related]
8. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
Lan X; Jhaveri A; Cheng K; Wen H; Saleem MA; Mathieson PW; Mikulak J; Aviram S; Malhotra A; Skorecki K; Singhal PC
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F326-36. PubMed ID: 24899058
[TBL] [Abstract][Full Text] [Related]
9. Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu.
Kumar V; Ayasolla K; Jha A; Mishra A; Vashistha H; Lan X; Qayyum M; Chinnapaka S; Purohit R; Mikulak J; Saleem MA; Malhotra A; Skorecki K; Singhal PC
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C209-C225. PubMed ID: 31116585
[TBL] [Abstract][Full Text] [Related]
10. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
11. Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.
Ekulu PM; Adebayo OC; Decuypere JP; Bellucci L; Elmonem MA; Nkoy AB; Mekahli D; Bussolati B; van den Heuvel LP; Arcolino FO; Levtchenko EN
Cells; 2021 Jul; 10(8):. PubMed ID: 34440683
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.
Gupta N; Waas B; Austin D; De Mazière AM; Kujala P; Stockwell AD; Li T; Yaspan BL; Klumperman J; Scales SJ
Sci Rep; 2024 Feb; 14(1):3765. PubMed ID: 38355600
[TBL] [Abstract][Full Text] [Related]
13. Protein domains of APOL1 and its risk variants.
Lan X; Wen H; Lederman R; Malhotra A; Mikulak J; Popik W; Skorecki K; Singhal PC
Exp Mol Pathol; 2015 Aug; 99(1):139-44. PubMed ID: 26091559
[TBL] [Abstract][Full Text] [Related]
14. Cation channel conductance and pH gating of the innate immunity factor APOL1 are governed by pore-lining residues within the C-terminal domain.
Schaub C; Verdi J; Lee P; Terra N; Limon G; Raper J; Thomson R
J Biol Chem; 2020 Sep; 295(38):13138-13149. PubMed ID: 32727852
[TBL] [Abstract][Full Text] [Related]
15. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles.
Bruno J; Pozzi N; Oliva J; Edwards JC
J Biol Chem; 2017 Nov; 292(44):18344-18353. PubMed ID: 28918394
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein L1 and mechanisms of kidney disease susceptibility.
Bruggeman LA; Sedor JR; O'Toole JF
Curr Opin Nephrol Hypertens; 2021 May; 30(3):317-323. PubMed ID: 33767059
[TBL] [Abstract][Full Text] [Related]
20. APOL1 Kidney Risk Variants Induce Cell Death
Shah SS; Lannon H; Dias L; Zhang JY; Alper SL; Pollak MR; Friedman DJ
J Am Soc Nephrol; 2019 Dec; 30(12):2355-2368. PubMed ID: 31558683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
